Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency

Perfusion

Volumn 21, Issue 2, 2006, Pages 117-120

  Schneider, Susan K ^a,b   Sakert, Tamara ^a   Lucke, John ^a   McKeown, Peter ^a   Sharma, Ajeet ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CCP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; PROTEIN C; PROTEIN S;

ADULT; ANESTHESIA; ARTICLE; ATTENUATION; BLOOD PUMP; BLOOD SAMPLING; CANNULA; CARDIOPULMONARY BYPASS; CAROTID ENDARTERECTOMY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DEEP VEIN THROMBOSIS; DOSE RESPONSE; HEMATOCRIT; HEMOSTASIS; HETEROZYGOSITY; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; LABORATORY TEST; LEUKOPENIA; LUNG EMBOLISM; MALE; PERFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; STROKE; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; ULTRAFILTRATION;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 33645782477     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659106pf853oa     Document Type: Article

References (21)

1. Petaja J, Pesonen E, Fernandez J, Vento AE, Ramo OJ, Griffin JH. Cardiopulmonary bypass and activation of antithrombotic plasma protein C. J Thorac Cardiovasc Surg 1999; 118: 422-31.
2. Nishioka J, Suzuki S. Inhibition of co-factor activity of protein S by a complex of protein S and C4b-binding protein. Evidence for inactive ternary complex formation between protein S, C4-b binding protein, and activated protein. J Biol Chem 1990; 265: 9072-76.
3. Tanaka K, Wada K, Morimoto T et al. The role of the protein C-thrombomodulin system in physiologic anticoagulation during cardiopulmonary bypass. Trans Am Soc Artif Intern Organs 1989; 35: 373-75.
4. Retrieved from http://www-admin.med.uiuc.edu/hematology
5. Eising GP, Pfauder M, Niemheyer M et al. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg 2003; 75: 23-27.
6. Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg 2002; 73: 1912-18.
7. Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion 2002; 17: 111-15.
8. Huang H, Yao T, Wang W et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 2003; 76: 136-40.
9. Onoe M, Magara T, Yamamoto Y, Nojima T. Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery. Perfusion 2000; 16: 37-42.
10. Luciani GB, Menon T, Vecchi B, Auriemma S, Mazzucco A. Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial. Circ J 2001; 104: 1253-59.
11. Kiziltepe U, Uysalel A, Corapcioglu T et al. Effects of combined conventional and modified ultrafiltration in adult patients. Ann Thorac Surg 2001; 71: 684-93.
12. Journois D. Hemofiltration during cardiopulmonary bypass. Kidney Intl 1998; 53: S174-77.
13. Thurlow PJ, Doolan L, Sharp R et al. Studies of the effect of Pall leukocyte filters LG6 and AV6 in an in-vitro simulated extracorporeal circulatory system. Perfusion 1995; 10: 291-300.
14. Palanzo DA, Manley NJ, Montesano RM et al. Clinical evaluation of the LeukoGuard (LG6) arterial line filter for routine open-heart surgery. Perfusion 1993; 8: 489-96.
15. De Paulis R, Bognolo G, Tomai F, Bassano C, Tracey M, Chiariello L. Early coronary artery bypass graft thrombosis in a patient with protein S deficiency. Eur J Cardiothorac Surg 1996; 10: 470-72.
16. Mahoneya CB, Lemoleb GM. Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits. Eur J Cardiothorac Surg 1999; 16: 206-10.
17. Ovrum E, Tangen G, Oystese R, Ringdal ML, Istad R. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. J Thorac Cardiovasc Surg 2001; 121: 324-30.
18. Shigeta O, Kojima H, Hiramatsu Y et al. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118: 354-60.
19. Kohler J, Kasper J, Witt I, von Reutern GM. Ischemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-80.
20. Arboix A, Bechich S, Oliveres M, Garcia-Eroles L, Massons J, Targa C. Ischemic stroke of unusual cause: clinical features, etiology, and outcome. Eur J Neurol 2001; 8: 133-39.
21. Ninomiya M, Makuuchi H, Ohtsuka T, Takamoto S. Ischemic heart disease associated with protein C deficiency. Eur J Cardiothorac Surg 2001; 20: 883-85.